• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Egypt
    • Novartis Site Directory
Novartis logo: a global healthcare company
  • Our Work
    • Information for Physicians
    • Therapeutic Areas
    • Our Process
    • Clinical Trials
    • Clinical Pipeline
    • Product Portfolio
  • About Us
    • Who We Are
    • Our Business
    • Corporate Responsibility
    • Contact Us
  • News
    • Global News Archive
    • News Archive
    • Stories
    • Media Releases
    • Media Contacts
  • Careers
    • Career Search
    • Working at Novartis Egypt
    • Employee Benefits
    • Awards & Recognition
Search

Email Us

General requests can be sent via email to: [email protected]

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Related Links

  • Information for Physicians
  • Product Related Issues
  • Corporate Responsibility in Egypt
  • Media Contacts

You are here

  1. Home ›
  2. About Us ›
  3. Contact Us

To report an adverse event or any drug related issues concerning Novartis medicianal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event. Fax: 002 02 26031702. E-mail: [email protected]

For safety labels, please click here and follow the below steps:  

  • Enter the name of the product in the search field

  • Select the result “Human medicine European public assessment report (EPAR)”

  • In product information section, click the link “EPAR- product information’ to download the last updated section of the EU SmPC

 

للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس

 +202 22861000 الهاتف:

ثم اضغط 3 للإبلاغ عن أثر جانبى

 002 02 26031702 الفاكس:

[email protected] البريد الإلكترونى

Novartis Egypt

  • Our Work
  • About Us
  • News
  • Actualité
  • Careers
  • Carrière
  • Locations
  • Sites
  • Contact Us

Subscribe to Novartis

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Instagram
  • Email
  • Novartis Site Directory
© 2022 Novartis AG

This site is intended for an audience in Egypt.

 

  • Terms of Use
  • Privacy Policy
  • About Cookies